Scivision Biotech (TPE:1786) Cyclically Adjusted Book per Share: NT$23.85 (As of Dec. 2025)


TPE:1786 Scivision Biotech Inc TPE:1786
80 GF Score
Price NT$53.50
GF Value NT$115.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Scivision Biotech Cyclically Adjusted Book per Share?

Scivision Biotech TPE:1786 -0.56% 80 Cyclically Adjusted Book per Share is NT$23.85 as of Dec. 2025. GuruFocus rates TPE:1786 with a GF Score™ of 80/100 and a GF Value™ of NT$115.23 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Scivision Biotech's adjusted book value per share for the three months ended in Dec. 2025 was NT$26.464. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.85 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Scivision Biotech's average Cyclically Adjusted Book Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Scivision Biotech was 11.90% per year. The lowest was 5.30% per year. And the median was 7.90% per year.

As of today (2026-07-09), Scivision Biotech's current stock price is NT$53.50. Scivision Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$23.85. Scivision Biotech's Cyclically Adjusted PB Ratio of today is 2.24.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scivision Biotech was 6.02. The lowest was 2.02. And the median was 3.39.


Scivision Biotech  (TPE:1786) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Scivision Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=53.50/23.85
=2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scivision Biotech was 6.02. The lowest was 2.02. And the median was 3.39.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Scivision Biotech Cyclically Adjusted Book per Share Related Terms


Scivision Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Scivision Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scivision Biotech Cyclically Adjusted Book per Share Chart

Scivision Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.23 20.43 22.09 22.92 23.85

Scivision Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.92 23.24 23.49 23.78 23.85

TPE:1786 vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Scivision Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scivision Biotech Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Scivision Biotech's Cyclically Adjusted PB Ratio falls into.


TPE:1786
80GF Score
Scivision Biotech Inc TPE:1786
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scivision Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scivision Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=26.464/324.0540*324.0540
=26.464

Current CPI (Dec. 2025) = 324.0540.

Scivision Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201603 15.242 238.132 20.742
201606 14.835 241.018 19.946
201609 14.075 241.428 18.892
201612 14.906 241.432 20.007
201703 14.327 243.801 19.043
201706 14.345 244.955 18.977
201709 14.887 246.819 19.545
201712 15.243 246.524 20.037
201803 15.814 249.554 20.535
201806 15.702 251.989 20.193
201809 17.014 252.439 21.841
201812 17.464 251.233 22.526
201903 20.597 254.202 26.257
201906 19.574 256.143 24.764
201909 19.960 256.759 25.191
201912 20.558 256.974 25.924
202003 21.107 258.115 26.499
202006 20.247 257.797 25.451
202009 20.761 260.280 25.848
202012 21.214 260.474 26.392
202103 21.587 264.877 26.410
202106 22.064 271.696 26.316
202109 21.483 274.310 25.379
202112 21.905 278.802 25.460
202203 22.313 287.504 25.150
202206 21.494 296.311 23.506
202209 22.182 296.808 24.218
202212 22.827 296.797 24.923
202303 23.864 301.836 25.621
202306 22.555 305.109 23.955
202309 23.572 307.789 24.818
202312 24.022 306.746 25.377
202403 22.665 312.332 23.516
202406 24.855 314.175 25.637
202409 25.959 315.301 26.680
202412 26.424 315.605 27.131
202503 24.159 319.799 24.480
202506 23.821 322.561 23.931
202509 26.604 324.800 26.543
202512 26.464 324.054 26.464

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$23.85 mean?
Scivision Biotech (TPE:1786) has a Cyclically Adjusted Book per Share of NT$23.85 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scivision Biotech and its competitors.
Is Scivision Biotech's Cyclically Adjusted Book per Share too high?
Scivision Biotech's current Cyclically Adjusted Book per Share is NT$23.85. Overall, Scivision Biotech has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's Cyclically Adjusted Book per Share compare to ISRG and BDX?
Scivision Biotech's Cyclically Adjusted Book per Share of NT$23.85 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scivision Biotech and its competitors. Scivision Biotech's current Cyclically Adjusted Book per Share is NT$23.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Possible Value Trap. The stock's GF Value™ is NT$115.23, compared to a current price of NT$53.50 — trading 53.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$23.85. Scivision Biotech's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current Cyclically Adjusted Book per Share is NT$23.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scivision Biotech (TPE:1786) Overvalued in 2026?

Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued. The current stock price of NT$53.50 is trading 53.6% below its estimated GF Value™ of NT$115.23. GuruFocus considers Scivision Biotech to be Possible Value Trap.

Key valuation signals for TPE:1786:

  • Cyclically Adjusted Book per Share: NT$23.85
  • GF Value™: NT$115.23 vs. price of NT$53.50 (53.6% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scivision Biotech Business Description

Address No. 1, South 1st Road, Qianzhen District, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
80GF Score

Get the complete analysis for TPE:1786

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$53.50
Price
NT$115.23
GF Value